Jennison Associates’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36M | Buy |
825,025
+272,739
| +49% | +$11.9M | 0.02% | 264 |
|
|
2025
Q1 | $15.1M | Sell |
552,286
-164,647
| -23% | -$4.51M | 0.01% | 356 |
|
|
2024
Q4 | $28.8M | Sell |
716,933
-80,748
| -10% | -$3.25M | 0.02% | 301 |
|
|
2024
Q3 | $37.8M | Buy |
797,681
+368,394
| +86% | +$17.4M | 0.02% | 268 |
|
|
2024
Q2 | $12.8M | Buy |
429,287
+3,367
| +0.8% | +$101K | 0.01% | 362 |
|
|
2024
Q1 | $17.1M | Buy |
+425,920
| New | +$17.1M | 0.01% | 355 |
|
|
2022
Q1 | – | Sell |
-182,326
| Closed | -$11.6M | – | 675 |
|
|
2021
Q4 | $11.6M | Sell |
182,326
-2,255
| -1% | -$143K | 0.01% | 430 |
|
|
2021
Q3 | $10.8M | Sell |
184,581
-2,120
| -1% | -$125K | 0.01% | 442 |
|
|
2021
Q2 | $9.06M | Hold |
186,701
| – | – | 0.01% | 469 |
|
|
2021
Q1 | $7.26M | Buy |
186,701
+117,346
| +169% | +$4.56M | 0.01% | 446 |
|
|
2020
Q4 | $4.3M | Sell |
69,355
-669
| -1% | -$41.5K | ﹤0.01% | 460 |
|
|
2020
Q3 | $2.26M | Buy |
+70,024
| New | +$2.26M | ﹤0.01% | 474 |
|